On Friday, 5 May, the WHO Director General declared an end to the Public Health Emergency of International Concern (PHEIC) for the disease caused by the coronavirus SARS-CoV-2. COVID-19 was declared a PHEIC on 30 January 2020. For more than three years, the pandemic wreaked… read more
On 4 May 2023, EUCOPE was announced as a member of the Health Technology Assessment (HTA) Stakeholder Network. The Network has been established to facilitate contributions by a wide range of stakeholders to policy development related to HTAs in the European Union (EU). Since its… read more
On the Commission’s proposal for the EU Pharmaceutical Package On 26 April, the European Commission published the EU Pharmaceutical Package, revising how the pharmaceutical system is regulated in the EU, which includes a proposal for a “master” Regulation, merging Commission Regulation No 726/2004, Orphan Medicinal… read more
In November 2020, the European Commission adopted the EU Pharmaceutical Strategy, aimed at creating a future-proof regulatory framework and at supporting the industry in promoting research and technologies that reach patients in order to fulfil their therapeutic needs while addressing market failures. As part of… read more
On March 22, in a workshop in the European Parliament hosted by MEP Weiss, the OD Expert Group presented its Policy Proposals for the revision of the OMP Regulation. Thanks to everyone who participated in the event, whether in-person or remotely . The OD Expert… read more
There is momentum for change. Join us to discuss how to make that change happen! The challenges we are facing today within rare diseases are complex and extensive. To understand and overcome these, we need to work together and share knowledge across countries, between expert… read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of nine (9) new members at its quarterly Members Meeting on February 14th, 2023 following Board approval. The new members joining EUCOPE network are Admedicum, Ardena, Avanzanite Bioscience, Emergent Biosolutions, Evoke Incisive Health, Insmed, Lif… read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of three (3) new Associate members on 1 January 2023. The new members joining EUCOPE network are: APCO Worldwide, RareLab and SKC. During the announcement, EUCOPE’s Secretary General Alexander Natz said, “The new year means… read more
A new initiative to boost research and development into rare and paediatric diseases will launch today [Thursday 8 December] at the European Health Summit. The ‘Rare Disease Moonshot’ is a commitment and collaboration between seven organisations to break down the barriers to finding new treatments and cures… read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of three (3) new members at its quarterly Members Meeting on October 19th 2022 following Board approval. The new members joining EUCOPE network are: Genesis Pharma, Mirati Therapeutics and Moderna. During the announcement, EUCOPE’s Secretary… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View